Company intelligence / Profile preview

NovaPro

Suzhou, Jiangsu, China

Ownership: Private
Development stage: Other

Overview

NovaPro Bioscience is a biotechnology company specializing in high-throughput protein expression and purification services. The company provides a wide range of recombinant proteins, enzymes, and antibodies to support research and development in the life sciences sector. Their core business focuses on delivering high-quality reagents and contract research services (CRO) to pharmaceutical companies and academic institutions globally. By leveraging advanced protein engineering technologies, NovaPro Bioscience facilitates drug discovery and diagnostic development through the production of complex biological molecules.

Modalities: Recombinant proteinAntibodyEnzyme
Industry: Drug Discovery Services

Beyond the preview

Go deeper on NovaPro.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NovaPro.

Explore the full profile